Clinical Trials · NCT06937060
Effect of Semaglutide in Patients With Psoriasis and Obesity
- Phase
- Phase 3
- Recruitment status
- Recruiting
- Sponsor
- The University of Hong Kong
- Enrollment
- 14
- Start date
- Mar 2025
- Locations
- 1 site, Hong Kong
- Primary endpoint
- Change in mean Psoriasis Area and Severity Index (PASI) before and after semaglutide treatment.